[1] | Alfred A. Bartolucci, Karan P. Singh, Ramalingham Shanmugam, 2004, “Empirical Bayesian analysis of the Poisson intervention and incidence parameters,” Mathematics and Computers in Simulation, Vol. 64, 393-399. |
[2] | Alphonse Kpozèhouen, Ahmadou Alioum, et al., 2004, “Use of a Bayesian Approach to Decide When to Stop a Therapeutic Trial: The Case of a Chemoprophylaxis Trial in Human Immunodeficiency Virus Infection,” American Journal of Epidemiology, Volume 161, Issue 6, 595-603. |
[3] | Berry, D.A., Wolff, M.C., Sack, D., 1994, “Decision making during a phase III randomized controlled trial,” Controlled Clinical Trials, 15, 360-78. |
[4] | Brenner, D., Fraser, D.A.S., and McDunnough, P., 1982, “On asymptotic normality of likelihood and conditional analysis,” can. J. Statist., 10, 163-172. |
[5] | Dankmar BoÈhning, 1998, “Zero-Inflated Poisson Models and C.A.MAN: A Tutorial Collection of Evidence”, Biometrical Journal, 40 (7), 833±843. |
[6] | Deuchert E, Brody S., 2007, “Plausible and implausible parameters for mathematical modeling of nominal heterosexual HIV transmission,” Ann Epidemiol., 17(3), 237-44. |
[7] | Elena E Giorgi, Bob Funkhouser, Gayathri Athreya, et al. (2010). “Estimating time since infection in early homogeneous HIV-1 samples using a poisson model,” BMC Bioinformatics, 11, 532. |
[8] | Fraser, D.A.S., and McDunnough, P. (1984). “Further remarks on asymptotic normality of likelihood and conditional analysis,” can. J. Statist., 12, 183-190. |
[9] | Gurprit Grover, Dulumoni Das and Rupak Gupta (2011). “On the Estimation of Expected Proportion of AIDS Cases Using Bayesian Approach,” The IUP Journal of Computational Mathematics, Vol. IV, No. 2, 37-48. |
[10] | H. Jeffreys., 1946, Methods of Mathematical Physics, Cambridge University Press. |
[11] | http://www.icmr.nic.in/icmrsql/insprofile.asp?insno1=000134 (20th April 2013) |
[12] | http://www.mapsofindia.com/maps/india/indiastateandunion.htm (25th June, 2013) |
[13] | http://www.nacoonline.org/NACO/About_NACO/Vision_and_Values/ (28th April 2013) |
[14] | Nel A, Louw C, Hellstrom E, Braunstein SL, Treadwell I, et al. (2011). “HIV Prevalence and Incidence among Sexually Active Females in Two Districts of South Africa to Determine Microbicide Trial Feasibility,” PLoS ONE 6(8): e21528. doi:10.1371/journal.pone.0021528. |
[15] | Pandey A, Sahu D, Bakkali T, et al. (2012), “Estimate of HIV prevalence and number of people living with HIV in India 2008-2009,” BMJ open 2012;2:e000926.doi:10.1136/bmjopen-2012-000926. |
[16] | Richard G. White, S. Cooper Ben et al. (2007). “Quantifying HIV-1 transmission due to contaminated injections,” PNAS vol. 104 no. 23, 9794-9799. |
[17] | Robbins, H., 1955, “An Empirical Bayes Approach to Statistics,” in 119-127. Proceedings of the 3rd Berke-ley Symposium on MathematicaI Statistics and Probability (Vol. l), Berkeley, CA: University of California Press, 157-163 |
[18] | Stephen R. Cole, Haitao Chu and Ron Brookmeyer (2007). Confidence Intervals for Biomarker-based Human Immunodeficiency Virus Incidence Estimates and Differences using Prevalent Data, American Journal of Epidemiology, 165, 94-100. |
[19] | W. Y. Tan, Tan Wai-Yuan (2000). Stochastic Modeling of AIDS Epidemiology And HIV Pathogenesis, World Scientific Publication, Singapore. |
[20] | Yinglin Xia, Dianne Morrison-Beedy, Jingming Ma, Changyong Feng, Wendi Cross, and Xin Tu (2012). “Modeling Count Outcomes from HIV Risk Reduction Interventions: A Comparison of Competing Statistical Models for Count Responses, AIDS Research and Treatment,” Article ID 593569. |